Journal article

The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome

Carl Lee, Shaun L Greene, Anselm Wong

Clinical Toxicology | TAYLOR & FRANCIS LTD | Published : 2019

Abstract

Introduction: Cannabinoid hyperemesis syndrome (CHS) can be characterized by recurrent paroxysmal episodes of intractable nausea and vomiting, abdominal pain, and compulsive hot showers/baths with symptom relief, on the background of chronic cannabis use. We reported the use of droperidol in the management of CHS. Methods: We performed a retrospective review of electronic medical records of Emergency Department presentations to a single tertiary level metropolitan hospital between January 2006 and December 2016 using search keywords: "cannabis", "cannabinoid", "cannabis", "hyperemesis", and "droperidol". A secondary search of pharmacy droperidol dispensing records was cross matched with elec..

View full abstract

University of Melbourne Researchers